HK1140777A1 - A type of consensus interferon and preparation method thereof - Google Patents
A type of consensus interferon and preparation method thereofInfo
- Publication number
- HK1140777A1 HK1140777A1 HK10107119.9A HK10107119A HK1140777A1 HK 1140777 A1 HK1140777 A1 HK 1140777A1 HK 10107119 A HK10107119 A HK 10107119A HK 1140777 A1 HK1140777 A1 HK 1140777A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- type
- consensus interferon
- consensus
- interferon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101013094A CN101525381B (zh) | 2008-03-04 | 2008-03-04 | 一种重组复合干扰素及其表达载体的构建和表达 |
| PCT/CN2009/070607 WO2009109129A1 (en) | 2008-03-04 | 2009-03-02 | A new type of consensus interferon and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1140777A1 true HK1140777A1 (en) | 2010-10-22 |
Family
ID=41055552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10107119.9A HK1140777A1 (en) | 2008-03-04 | 2010-07-23 | A type of consensus interferon and preparation method thereof |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20100266536A1 (xx) |
| EP (1) | EP2262829B1 (xx) |
| CN (2) | CN101525381B (xx) |
| HK (1) | HK1140777A1 (xx) |
| WO (1) | WO2009109129A1 (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10308697B2 (en) | 2014-04-30 | 2019-06-04 | President And Fellows Of Harvard College | Fusion proteins for treating cancer and related methods |
| EP3577133A1 (en) | 2017-02-06 | 2019-12-11 | Orionis Biosciences NV | Targeted chimeric proteins and uses thereof |
| WO2018144999A1 (en) | 2017-02-06 | 2018-08-09 | Orionis Biosciences, Inc. | Targeted engineered interferon and uses thereof |
| CN109485718B (zh) * | 2018-11-28 | 2019-08-30 | 深圳市利云德生物技术有限公司 | 一种新型干扰素α及其制备方法、组合物和用途 |
| EP3946410A4 (en) | 2019-03-28 | 2023-06-28 | Orionis Biosciences, Inc. | Therapeutic interferon alpha 1 proteins |
| WO2020257412A1 (en) * | 2019-06-19 | 2020-12-24 | Orionis Biosciences, Inc. | Combination therapy with cd13-targeted chimeric proteins or chimeric protein complexes |
| CN113009156B (zh) * | 2021-03-22 | 2022-08-12 | 华南农业大学 | 一种利用绿色荧光蛋白报告基因检测犬IFN-α生物学活性的方法 |
| CN116120424A (zh) * | 2022-06-06 | 2023-05-16 | 江苏靶标生物医药研究所有限公司 | 一种干扰素α2b可溶性重组表达和分离纯化方法及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
| US5372808A (en) * | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
| US5831062A (en) * | 1996-05-09 | 1998-11-03 | Amgen Inc. | Use of the human interferon consensus gene for gene therapy |
| DE69838552T2 (de) * | 1997-07-14 | 2008-05-21 | Bolder Biotechnology, Inc., Louisville | Derivate des wachstumshormons und verwandte proteine |
| US6114145A (en) * | 1997-12-05 | 2000-09-05 | Human Genome Sciences, Inc. | Synferon, a synthetic interferon |
| SI1075281T1 (en) * | 1998-04-28 | 2005-02-28 | Applied Research Systems Ars Holding N.V. | Polyol-ifn-beta conjugates |
| CN1062565C (zh) * | 1998-06-29 | 2001-02-28 | 深圳九先生物工程有限公司 | 重组人α型复合干扰素及其制备方法和用途 |
| EP1355939A2 (en) * | 2000-11-03 | 2003-10-29 | Pestka Biomedical Laboratories, Inc. | Interferons, uses and compositions related thereto |
| CN1245215C (zh) * | 2001-02-28 | 2006-03-15 | 四川省生物工程研究中心 | 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂 |
| US7314613B2 (en) * | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| JP2006519235A (ja) * | 2003-02-26 | 2006-08-24 | インターミューン インコーポレイティッド | ポリエチレングリコール修飾インターフェロン組成物およびその使用方法 |
| CN1570117A (zh) * | 2003-07-18 | 2005-01-26 | 中国科学院微生物研究所 | 一种表达复合干扰素的方法和用于该方法的载体 |
| CN1589899A (zh) * | 2003-08-27 | 2005-03-09 | 北京双鹭药业股份有限公司 | 重组新型复合干扰素在预防和治疗非典型肺炎中的应用 |
| AU2006257286B2 (en) * | 2005-03-09 | 2012-08-16 | Superlab Far East Limited | Uses of recombinant super-compound interferons |
| CN1970572A (zh) * | 2006-12-21 | 2007-05-30 | 北京三元基因工程有限公司 | 干扰素α突变体及其聚乙二醇衍生物 |
-
2008
- 2008-03-04 CN CN2008101013094A patent/CN101525381B/zh not_active Expired - Fee Related
-
2009
- 2009-03-02 EP EP09718078.0A patent/EP2262829B1/en not_active Not-in-force
- 2009-03-02 US US12/446,519 patent/US20100266536A1/en not_active Abandoned
- 2009-03-02 WO PCT/CN2009/070607 patent/WO2009109129A1/en active Application Filing
- 2009-03-02 CN CN2009800001779A patent/CN101679502B/zh not_active Expired - Fee Related
-
2010
- 2010-07-23 HK HK10107119.9A patent/HK1140777A1/xx not_active IP Right Cessation
-
2012
- 2012-07-23 US US13/555,930 patent/US8496921B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2262829A4 (en) | 2011-04-13 |
| US8496921B2 (en) | 2013-07-30 |
| CN101679502A (zh) | 2010-03-24 |
| US20100266536A1 (en) | 2010-10-21 |
| CN101525381A (zh) | 2009-09-09 |
| CN101525381B (zh) | 2012-04-18 |
| CN101679502B (zh) | 2012-07-11 |
| EP2262829B1 (en) | 2014-01-22 |
| US20120288477A1 (en) | 2012-11-15 |
| EP2262829A1 (en) | 2010-12-22 |
| WO2009109129A1 (en) | 2009-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1140777A1 (en) | A type of consensus interferon and preparation method thereof | |
| EP2517851A4 (en) | WOOD SECTION AND PREPARATION METHOD THEREOF | |
| GB0806768D0 (en) | Article and method of manufacture thereof | |
| ZA201107702B (en) | Composition and methods related to protein a(spa)variants | |
| IL217745A0 (en) | Antiviral compounds and methods of making and using thereof | |
| IL215190A0 (en) | A natural taste enhancing savoury base and a process for its preparation | |
| GB2470875B (en) | Combustor component and method of manufacture | |
| EP2513263A4 (en) | DIESEL COMPOSITION AND PROCESS FOR PREPARING THE SAME | |
| EP2512309A4 (en) | GRID AND METHOD OF USE | |
| GB2452932B (en) | A turbine and a method of manufacture | |
| EP2394979A4 (en) | INTERMEDIATE OF CILASTATIN AND METHOD FOR PREPARING THE SAME | |
| GB2458367B (en) | Protective suit and methods of manufacture thereof | |
| EP2284144A4 (en) | POLYFLUORO-1-ALKANE AND METHOD FOR PRODUCING THE SAME | |
| ZA201204133B (en) | Health-beneficial preparation and production method | |
| ZA201203060B (en) | Composition and method of delivery | |
| GB2485953B (en) | Methods of making and using a ruminant gas reduction composition | |
| GB2465115B (en) | A novel powder and its method of manufacture | |
| IL178698A0 (en) | A coating and method of preparing same | |
| GB201210536D0 (en) | Composition, use and method of preparation thereof | |
| IL192552A0 (en) | Dnt-succinate and methods of preparation thereof | |
| EP2508598A4 (en) | PREPARATION OF LIPASE POWDER AND USE THEREOF | |
| PL385716A1 (pl) | Sposób wytwarzania i pakowania sztućców jednorazowego użytku | |
| GB0914327D0 (en) | Resistor and method of manufacture | |
| EP2252265A4 (en) | INJECTABLE PREPARATIONS AND MANUFACTURING METHOD THEREFOR | |
| IL190726A0 (en) | Dnt-benzenesulfonate and methods of preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210302 |